WALTHAM, Mass., Nov. 25, 2014 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that Lonnie Moulder, CEO of TESARO, will present at the Nasdaq 31st Investor Program on Tuesday, December 2, 2014 at 10:15 a.m. GMT in London.
A live webcast will be accessible via the Investors page of the TESARO website at www.tesarobio.com. An archived replay of this webcast will be available on the Company's website for 14 days after the conference.
About TESARO
TESARO, Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.